Covid-19 Archives - Investigate Europe

10 March 2021 Vaccines

Europe blocks move that would massively expand Covid vaccine production capacity. Why?

By Ingeborg Eliassen

A few companies own the Covid-19 vaccines, but they are not able to make nearly enough. Why do European countries continue to dismiss a demand that would let all factories with spare capacity to produce more vaccines? Read more "Europe blocks move that would massively expand Covid vaccine production capacity. Why?"

16 February 2021 Vaccines

In the fight against Covid-19, patents are deadly

By Harald Schumann

Europe and America are protecting the pharmaceutical industry instead of their population Read more "In the fight against Covid-19, patents are deadly"

25 September 2020 Vaccines

Business interests vs vaccine idealism at CEPI

By Ingeborg Eliassen

The Coalition for Epidemic Preparedness Innovations was born to ensure fair access to vaccines. But before the Covid-19 pandemic, CEPI learned the name of the game the hard way. Read more "Business interests vs vaccine idealism at CEPI"

12 June 2020 The 5G mass experiment

Real 5G issues overshadowed by Covid-19 conspiracy theories

By Ingeborg Eliassen and Paulo Pena

Unsubstantiated claims that connect the new mobile technology to the spread of the Coronavirus pandemic have led people to destroy 5G masts in several countries. Such actions overshadow concerns about health effects of the technology that are real and legitimate. Read more "Real 5G issues overshadowed by Covid-19 conspiracy theories"

13 May 2020 Vaccines

Reinhilde Veugelers, Belgian economist: “Governments must fully finance the development of the vaccine”

By Ingeborg Eliassen

Reinhilde Veugelers: Senior Fellow at Bruegel, Professor at Faculty of Economics and Business at the Catholic University of Leuven. Co-author of the April 2020 report Racing against Covid-19: A vaccine strategy for Europe. Why did you make this report? In discussions about Covid-19, it has … Read more "Reinhilde Veugelers, Belgian economist: “Governments must fully finance the development of the vaccine”"

13 May 2020 Vaccines

European Alliance for Responsible R&D and Affordable Medicines: “If the public is an investor, it should act like one and demand something in return”

By Ingeborg Eliassen

The European Alliance for Responsible R&D and Affordable Medicines sprang out of a price conflict between Germany, France and the US drug producer Gilead on price of Sovaldi, a treatment for hepatitis C, in 2014. Rich Western countries such as France and Italy couldn’t afford the drug … Read more "European Alliance for Responsible R&D and Affordable Medicines: “If the public is an investor, it should act like one and demand something in return”"